Predicting interactions between the SARS-CoV-2 spike glycoprotein and the human proteome using AphaFold and molecular dynamics simulations
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Since the COVID-19 pandemic began, the SARS-CoV-2 virus has caused over 775 million cases and more than 7 million deaths worldwide. Despite progress in treatments and vaccines, we still need better ways to prevent and treat the disease. To do this, a clearer understanding of how SARS-CoV-2 interacts with human proteins is needed. We developed a new computational tool to predict and study these protein-protein interactions. Our method uses two stages of AlphaFold, an AI tool, to predict how SARS-CoV-2 proteins bind to human proteins, followed by molecular dynamics simulation to refine these predictions. We tested this method in a small study focusing on the S1 subunit of the SARS-CoV-2 spike protein interacting with human cell junction and synaptic proteins, and in a larger study screening the spike S1 N- terminal domain against the entire human proteome. We validated the method using experimental virus–human protein interactions. The results provide valuable insights into how SARS-CoV-2 interacts with human proteins, guiding future experiments to better understand COVID-19’s short- and long-term effects. This developed method could be utilized to study protein-protein interactions in other biological systems.
